Moxibustion for diarrhea-predominant irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials

Complement Ther Clin Pract. 2022 Feb:46:101532. doi: 10.1016/j.ctcp.2021.101532. Epub 2022 Jan 3.

Abstract

Purpose: Diarrhea-predominant irritable bowel syndrome (IBS-D) is a common functional gastrointestinal disorder that imposes heavy burden on individuals and society. Asan external therapy of traditional Chinese medicine (TCM), moxibustion is usually used to treat IBS-D. This study aimed to explore the efficacy of moxibustion in treating patients with IBS-D.

Methods: A systematic search for randomized controlled trials (RCTs) that reported the use of moxibustion in IBS-D treatment was performed in eight databases.

Results: Eleven RCTs including 725 participants meet the inclusion criteria. Compared with other positive treatments (Western medicine, TCM prescription, and acupuncture), moxibustion treatment had superior effects against IBS-D according to the meta-analysis.

Conclusion: This systematic review provided preliminary research evidence that moxibustion is effective in treating IBS-D. Rigorously designed and large-scale RCTs are required to provide more robust evidence in this area.

Keywords: Diarrhea; Irritable bowel syndrome; Moxibustion; Systematic review.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Acupuncture Therapy*
  • Diarrhea / therapy
  • Humans
  • Irritable Bowel Syndrome* / therapy
  • Moxibustion*
  • Randomized Controlled Trials as Topic